PODESTA GROUP, INC. for MILLENNIUM PHARMACEUTICALS INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription Drug User Fee Act reauthorization.
Foreign entity interest: Takeda Pharmaceuticals Co. Ltd. to the degree that public policies, either laws or regulations, commcercially benefit Millenium: The Takeda Oncology Company, so too Takeda Pharmaceuticals Co. Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Health Issues HCR
Patient Protection and Affordable Care Act implementation. 340B-related issues.
Foreign entity interest: Takeda Pharmaceuticals Co. Ltd. to the degree that public policies, either laws or regulations, commcercially benefit Millenium: The Takeda Oncology Company, so too Takeda Pharmaceuticals Co. Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANNE MARIE POLAK | — |
| THOMAS B SPARKMAN | — |
Medicare/Medicaid MMM
Medicare coverage and reimbursement. Monitor debt ceiling negotiations, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
Foreign entity interest: Takeda Pharmaceuticals Co. Ltd. to the degree that public policies, either laws or regulations, commcercially benefit Millenium: The Takeda Oncology Company, so too Takeda Pharmaceuticals Co. Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANNE MARIE POLAK | — |
| THOMAS B SPARKMAN | — |
Copyright/Patent/Trademark CPT
H.R. 1249/S. 23, America Invents Act.
Foreign entity interest: Takeda Pharmaceuticals Co. Ltd. to the degree that public policies, either laws or regulations, commcercially benefit Millenium: The Takeda Oncology Company, so too Takeda Pharmaceuticals Co. Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Budget/Appropriations BUD
FY 2012 Budget resolutions. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
Foreign entity interest: Takeda Pharmaceuticals Co. Ltd. to the degree that public policies, either laws or regulations, commcercially benefit Millenium: The Takeda Oncology Company, so too Takeda Pharmaceuticals Co. Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.